Market Trends Acelyrin jumps 11% on acquisition offer from Concentra Biosciences (SLRN:NASDAQ)By admin8996erT0allFebruary 21, 2025 Acelyrin (NASDAQ:SLRN) received an unsolicited acquisition offer from Concentra Biosciences, controlled by Tang Capital Partners. The proposal includes a cash…
Market Trends Becton Dickinson aims to split off biosciences unit, as Starboard calls for the sameBy admin8996erT0allFebruary 8, 2025 Pavlo Gonchar | Sopa Images | Lightrocket | Getty ImagesCompany: Becton Dickinson and Co (BDX)Business: Becton Dickinson develops, manufactures and…
Market Trends Pacira BioSciences stock upgraded at Truist (PCRX:NASDAQ)By admin8996erT0allJanuary 30, 2025 CatLaneTruist upgraded pain therapy developer Pacira BioSciences (NASDAQ:PCRX) to Hold from Sell on Thursday, noting that the company’s management is…
